Campbell Newman Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $494K | Buy |
|
|||||
|
2020
Q3 | $417K | Buy |
|
|||||
|
2020
Q2 | $463K | Buy |
|
|||||
|
2020
Q1 | $439K | Sell |
|
|||||
|
2019
Q4 | $601K | Sell |
|
|||||
|
2019
Q3 | $567K | Sell |
|
|||||
|
2019
Q2 | $563K | Buy |
|
|||||
|
2019
Q1 | $476K | Buy |
|
|||||
|
2018
Q4 | $371K | Buy |
|
|||||
|
2018
Q3 | $571K | Buy |
|
|||||
|
2018
Q2 | $591K | Buy |
|
|||||
|
2018
Q1 | $208K | Buy |
|
|||||
|
2017
Q4 | $200K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $212K | Buy |
|
|||||
|
2017
Q1 | $213K | Buy |
|